QA: AKORN INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000003116_2018_AKORN_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000003116')"}

Graph

Absolute values for 0000003116, AKORN INC

  xvar xval
0 AssetsCurrent 730,151,000
1 IntangibleAssetsNetIncludingGoodwill 854,794,000
2 PropertyPlantAndEquipmentNet 313,418,000
3 remainder_Assets 11,148,000
4 LiabilitiesCurrent 171,089,000
5 LiabilitiesNoncurrent 907,177,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 407,898,000
8 SellingGeneralAndAdministrativeExpense 216,086,000
9 ResearchAndDevelopmentExpense 80,502,000
10 remainder_Expenses 124,783,000
11 remainder_Revenues 841,045,000
12 remainder_NetIncome -36,326,000
13 remainder_ComprehensiveNetIncome 7,999,000
  yvar yval
0 Assets 1,909,511,000
1 Liabilities 1,078,266,000
2 Expenses 829,269,000
3 Revenues 841,045,000
4 StockholdersEquity 831,245,000
5 NetIncome -24,550,000
6 ComprehensiveNetIncome -20,550,500
7 BaseVar 2,351,208,000
8 EconomicCapitalRatio 0.943

Edgar->Model Mapping

Feature Distribution

Change over Time